Combined hormonal contraception and bone health: a systematic review

Contraception

Volumn 73, Issue 5, 2006, Pages 445-469

  Martins, Summer L ^a   Curtis, Kathryn M ^a   Glasier, Anna F ^b,c,d  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b National Health Service   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Bone mineral density; Fracture; Hormonal contraception; Systematic reviews

Indexed keywords

DESOGESTREL; DROSPIRENONE; ESTRADIOL VALERATE PLUS NORETHISTERONE ENANTATE; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS ETONOGESTREL; GESTAGEN; GESTODENE; LEVONORGESTREL; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT;

BONE DENSITY; BONE DESTRUCTION; CLIMACTERIUM; DRUG EFFECT; DRUG MEGADOSE; DRUG USE; EMBASE; EVIDENCE BASED MEDICINE; FETUS DEATH; FRACTURE; GROUPS BY AGE; HIP FRACTURE; HORMONAL CONTRACEPTION; HORMONE SUBSTITUTION; HUMAN; INFORMATION RETRIEVAL; LOW DRUG DOSE; MEDLINE; OSTEOLYSIS; POSTMENOPAUSE; PREMENOPAUSE; PUBLICATION; REVIEW; RIB FRACTURE; RISK; SIDE EFFECT; SKULL FRACTURE; SPINE FRACTURE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VERTEBRA MALFORMATION;

AGE FACTORS; BONE DENSITY; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; FRACTURES, BONE; HUMANS; MENOPAUSE;

EID: 33646034875     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2006.01.003     Document Type: Review

References (106)

1. Cromer B.A. Effects of hormonal contraceptives on bone mineral density. Drug Saf 20 (1999) 213-222
2. DeCherney A. Bone-sparing properties of oral contraceptives. Am J Obstet Gynecol 174 (1996) 15-20
3. Kuohung W., Borgatta L., and Stubblefield P. Low-dose oral contraceptives and bone mineral density: an evidence-based analysis. Contraception 61 (2000) 77-82
4. Williams J.K. Noncontraceptive benefits of oral contraceptive use: an evidence-based approach. Int J Fertil Womens Med 45 (2000) 241-247
5. Compston J. Sex steroids and bone. Physiol Rev 81 (2001) 419-447
6. Castelo-Branco C., Vicente J.J., Pons F., Martinez de Osaba M.J., Casals E., and Vanrell J.A. Bone mineral density in young, hypothalamic oligoamenorrheic women treated with oral contraceptives. J Reprod Med 46 (2001) 875-879
7. Haenggi W., Casez J.-P., Birkhauser M., Lippuner K., and Jaeger P. Bone mineral density in young women with long-standing amenorrhea: limited effect of hormone replacement therapy with ethinylestradiol and desogestrel. Osteoporos Int 4 (1994) 99-103
8. Hergenroeder A.C., Smith E.O., Shypailo R., Jones L.A., Klish W.J., and Ellis K. Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months. Am J Obstet Gynecol 176 (1997) 1017-1025
9. Rickenlund A., Carlstrom K., Ekblom B., Brismar T.B., Von S.B., and Hirschberg A.L. Effects of oral contraceptives on body composition and physical performance in female athletes. J Clin Endocrinol Metab 89 (2004) 4364-4370
10. Seeman E., Szmukler G.I., Formica C., Tsalamandris C., and Mestrovic R. Osteoporosis in anorexia nervosa: the influence of peak bone density, bone loss, oral contraceptive use, and exercise. J Bone Miner Res 7 (1992) 1467-1474
11. Doren M., Nilsson J., and Johnell O. Effects of specific post-menopausal hormone therapies on bone mineral density in post-menopausal women: a meta-analysis. Hum Reprod 18 (2003) 1737-1746
12. WHO. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843 (1994) 1-129
13. Marshall D., Johnell O., and Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312 (1996) 1254-1259
14. Melton III L.J., Crowson C., O'Fallon W., Wahner H., and Riggs L. Relative contributions of bone density, bone turnover, and clinical risk factors to long-term fracture prediction. J Bone Miner Res 18 (2003) 312-318
15. Siris E., Brenneman S., Miller P., et al. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and older: results from the National Osteoporosis Risk Assessment (NORA). J Bone Miner Res 19 (2004) 1215-1220
16. Grimes D., and Schulz K. Surrogate end points in clinical research: hazardous to your health. Obstet Gynecol 105 (2005) 1114-1118
17. Sandor T., Felsenberg D., and Brown E. Comments on the hypotheses underlying fracture risk assessment in osteoporosis as proposed by the World Health Organization. Calcif Tissue Int 64 (1999) 267-270
18. Schonau E. The peak bone mass concept: is it still relevant?. Pediatr Nephrol 19 (2004) 825-831
19. Harris R., Helfand M., Woolf S., et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 20 (2001) 20-35
20. Cooper C., Hannaford P., Croft P., and Kay C.R. Oral contraceptive pill use and fractures in women: a prospective study. Bone 14 (1993) 41-45
21. Johansson C., and Mellstrom D. An earlier fracture as a risk factor for new fracture and its association with smoking and menopausal age in women. Maturitas 24 (1996) 97-106
22. La Vecchia C., Tavani A., and Gallus S. Oral contraceptives and risk of hip fractures. Lancet 354 (1999) 335-336
23. Mallmin H., Ljunghall S., Persson I., and Bergstrom R. Risk factors for fractures of the distal forearm: a population-based case-control study. Osteoporos Int 4 (1994) 298-304
24. Michaelsson K., Baron J.A., Farahmand B.Y., Persson I., and Ljunghall S. Oral contraceptive use and risk of hip fracture: a case-control study. Lancet 353 (1999) 1481-1484
25. Michaelsson K., Baron J.A., Farahmand B.Y., and Ljunghall S. Influence of parity and lactation on hip fracture risk. Am J Epidemiol 153 (2001) 1166-1172
26. O'Neill T.W., Marsden D., Adams J.E., and Silman A.J. Risk factors, falls, and fracture of the distal forearm in Manchester, UK. J Epidemiol Community Health 50 (1996) 288-292
27. O'Neill T.W., Silman A.J., Naves D.M., Cooper C., Kanis J., and Felsenberg D. Influence of hormonal and reproductive factors on the risk of vertebral deformity in European women. European Vertebral Osteoporosis Study Group. Osteoporos Int 7 (1997) 72-78
28. Tuppurainen M., Kroger H., Saarikoski S., Honkanen R., and Alhava E. The effect of previous oral contraceptive use on bone mineral density in perimenopausal women. Osteoporos Int 4 (1994) 93-98
29. Vessey M., Mant J., and Painter R. Oral contraception and other factors in relation to hospital referral for fracture. Findings in a large cohort study. Contraception 57 (1998) 231-235
30. Barad D., Kooperberg C., Wactawsi-Wende J., Liu J., Hendrix S., and Watts N. Prior oral contraception and postmenopausal fracture: a Women's Health Initiative observational cohort study. Fertil Steril 84 (2005) 374-383
31. Afghani A., Abbott A.V., Wiswell R.A., et al. Bone mineral density in Hispanic women: role of aerobic capacity, fat-free mass, and adiposity. Int J Sports Med 25 (2004) 384-390
32. Beksinska M., Smit J., Kleinschmidt I., Farley T., and Mbatha F. Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception. Contraception 71 (2005) 170-175
33. Berning B., van K.C., Schutte H.E., Kuiper J.W., Drogendijk A.C., and Fauser B.C. Determinants of lumbar bone mineral density in normal weight, non-smoking women soon after menopause. A study using clinical data and quantitative computed tomography. Bone Miner 21 (1993) 129-139
34. Collins C., Thomas K., Harding A., Cook S., Turner J., and Collins J. The effect of oral contraceptives on lumbar bone density in premenopausal women. J La State Med Soc 140 (1988) 35-39
35. Forsmo S., Schei B., Langhammer A., and Forsen L. How do reproductive and lifestyle factors influence bone density in distal and ultradistal radius of early postmenopausal women? The Nord-Trondelag Health Survey, Norway. Osteoporos Int 12 (2001) 222-229
36. Fortney J.A., Feldblum P.J., Talmage R.V., Zhang J., and Godwin S.E. Bone mineral density and history of oral contraceptive use. J Reprod Med 39 (1994) 105-109
37. Garnero P., Sornay-Rendu E., and Delmas P.D. Decreased bone turnover in oral contraceptive users. Bone 16 (1995) 499-503
38. Goldsmith N., and Johnston J. Bone mineral: effects of oral contraceptives, pregnancy, and lactation. J Bone Joint Surg 57-A (1975) 657-668
39. Grainge M.J., Coupland C.AC., Cliffe S.J., Chilvers C.ED., and Hosking D.J. Reproductive, menstrual and menopausal factors: which are associated with bone mineral density in early postmenopausal women?. Osteoporos Int 12 (2001) 777-787
40. Hall M.L., Heavens J., Cullum I.D., and Ell P.J. The range of bone density in normal British women. J Bone Joint Surg 63 (1990) 266-269
41. Hansen M.A. Assessment of age and risk factors on bone density and bone turnover in healthy premenopausal women. Osteoporos Int 4 (1994) 123-128
42. Hartard M., Bottermann P., Bartenstein P., Jeschke D., and Schwaiger M. Effects on bone mineral density of low-dosed oral contraceptives compared to and combined with physical activity. Contraception 55 (1997) 87-90
43. Hawker G.A., Forsmo S., Cadarette S.M., et al. Correlates of forearm bone mineral density in young Norwegian women: the Nord-Trondelag health study. Am J Epidemiol 156 (2002) 418-427
44. Hreshchyshyn M.M., Hopkins A., Zylstra S., and Anbar M. Associations of parity, breast-feeding, and birth control pills with lumbar spine and femoral neck bone densities. Am J Obstet Gynecol 159 (1988) 318-322
45. Johnell O., and Nilsson B.E. Life-style and bone mineral mass in perimenopausal women. Calcif Tissue Int 36 (1984) 354-356
46. Kanders B., Lindsay R., and Dempster D. Determinants of bone mass in young healthy women. In: Christiansen C., Arnaud C., Nordin B., Parfitt A., Peck W., and Riggs B. (Eds). Proceedings of the Copenhagen International Symposium on Osteoporosis, Copenhagen (1984), Department of Clinical Chemistry, Glostrup Hospital, Denmark 337-339
47. Kleerekoper M., Brienza R.S., Schultz L.R., and Johnson C.C. Oral contraceptive use may protect against low bone mass. Henry Ford Hospital Osteoporosis Cooperative Research Group. Arch Intern Med 151 (1991) 1971-1976
48. Kritz-Silverstein E., and Barrett-Connor D. Bone mineral density in postmenopausal women as determined by prior oral contraceptive use. Am J Public Health 83 (1993) 100-102
49. Laitinen K., Valimaki M., and Keto P. Bone mineral density measured by dual-energy X-ray absorptiometry in healthy Finnish women. Calcif Tissue Int 48 (1991) 224-231
50. Lau E.MC., Lynn H., Woo J., and Melton III L.J. Areal and volumetric bone density in Hong Kong Chinese: a comparison with Caucasians living in the United States. Osteoporos Int 14 (2003) 583-588
51. Lindsay R., Tohme J., and Kanders B. The effect of oral contraceptive use on vertebral bone mass in pre- and post-menopausal women. Contraception 34 (1986) 333-340
52. Lloyd T., Buchanan J.R., Ursino G.R., Myers C., Woodward G., and Halbert D.R. Long-term oral contraceptive use does not affect trabecular bone density. Am J Obstet Gynecol 160 (1989) 402-404
53. Lloyd T., Taylor D.S., Lin H.M., Matthews A.E., Eggli D.F., and Legro R.S. Oral contraceptive use by teenage women does not affect peak bone mass: a longitudinal study. Fertil Steril 74 (2000) 734-738
54. Lloyd T., Petit M.A., Lin H.M., and Beck T.J. Lifestyle factors and the development of bone mass and bone strength in young women. J Pediatr 144 (2004) 776-782
55. MacDougall J., Davies M.C., Overton C.E., et al. Bone density in a population of long term oral contraceptive pill users does not differ from that in menstruating women. Br J Fam Plann 25 (1999) 96-100
56. Masaryk P., Lunt M., Benevolenskaya L., et al. Effects of menstrual history and use of medications on bone mineral density: the EVOS study. Calcif Tissue Int 63 (1998) 271-276
57. Melton III L.J., Bryant S.C., Wahner H.W., et al. Influence of breastfeeding and other reproductive factors on bone mass later in life. Osteoporos Int 3 (1993) 76-83
58. Murphy S., Khaw K.T., and Compston J.E. Lack of relationship between hip and spine bone mineral density and oral contraceptive use. Eur J Clin Invest 23 (1993) 108-111
59. Nelson M., Mayer A.B., Rutherford O., and Jones D. Calcium intake, physical activity and bone mass in pre-menopausal women. J Hum Nutr Diet 4 (1991) 171-178
60. Ott S.M., Scholes D., LaCroix A.Z., Ichikawa L.E., Yoshida C.K., and Barlow W.E. Effects of contraceptive use on bone biochemical markers in young women. J Clin Endocrinol Metab 86 (2001) 179-185
61. Pasco J.A., Kotowicz M.A., Henry M.J., Panahi S., Seeman E., and Nicholson G.C. Oral contraceptives and bone mineral density: a population-based study. Am J Obstet Gynecol 182 (2000) 265-269
62. Perrotti M., Bahamondes L., Petta C., and Castro S. Forearm bone density in long-term users of oral combined contraceptives and depot medroxyprogesterone acetate. Fertil Steril 76 (2001) 469-473
63. Petitti D.B., Piaggio G., Mehta S., Cravioto M.C., and Meirik O. Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population. The WHO Study of Hormonal Contraception and Bone Health. Obstet Gynecol 95 (2000) 736-744
64. Picard D., Ste-Marie L.G., Coutu D., et al. Premenopausal bone mineral content relates to height, weight and calcium intake during early adulthood. Bone Miner 4 (1988) 299-309
65. Prior J.C., Kirkland S.A., Joseph L., et al. Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study. CMAJ 165 (2001) 1023-1029
66. Progetto Menopausa Italia Study Group. Risk of low bone density in women attending menopause clinics in Italy. Maturitas 42 (2002) 105-111
67. Rodin A., Chapman M., and Fogelman I. Bone density in users of combined oral contraception. Preliminary reports of a pilot study. Br J Fam Plann 16 (1991) 125-129
68. Sowers M.F., Wallace R.B., and Lemke J.H. Correlates of forearm bone mass among women during maximal bone mineralization. Prev Med 14 (1985) 585-596
69. Stevenson J.C., Lees B., Devenport M., Cust M.P., and Ganger K.F. Determinants of bone density in normal women: risk factors for future osteoporosis?. Br Med J (Clin Res Ed) 298 (1989) 924-928
70. Sultana S., Choudhury S., and Choudhury S.A. Effect of combined oral contraceptives on bone mineral density in pre and postmenopausal women. Mymensingh Med J 11 (2002) 12-14
71. Tavani A., La V.C., and Franceschi S. Oral contraceptives and bone mineral density. Am J Obstet Gynecol 184 (2001) 249-250
72. Tharnprisarn W., and Taneepanichskul S. Bone mineral density in adolescent and young Thai girls receiving oral contraceptives compared with depot medroxyprogesterone acetate: a cross-sectional study in young Thai women. Contraception 66 (2002) 101-103
73. Ulrich C.M., Georgiou C.C., Snow-Harter C.M., and Gillis D.E. Bone mineral density in mother-daughter pairs: relations to lifetime exercise, lifetime milk consumption, and calcium supplements. Am J Clin Nutr 63 (1996) 72-79
74. Wallace L.S., and Ballard J.E. Lifetime physical activity and calcium intake related to bone density in young women. J Womens Health Gend Based Med 11 (2002) 389-398
75. Wanichsetakul P., Kamudhamas A., Watanaruangkovit P., Siripakarn Y., and Visutakul P. Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception. Contraception 65 (2002) 407-410
76. Berenson A.B., Radecki C.M., Grady J.J., Rickert V.I., and Thomas A. A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstet Gynecol 98 (2001) 576-582
77. Berenson A.B., Breitkopf C.R., Grady J.J., Rickert V.I., and Thomas A. Effects of hormonal contraception on bone mineral density after 24 months of use. Obstet Gynecol 103 (2004) 899-906
78. Cobb K.L., Kelsey J.L., Sidney S., Ettinger B., and Lewis C.E. Oral contraceptives and bone mineral density in white and black women in CARDIA. Coronary Risk Development in Young Adults. Osteoporos Int 13 (2002) 893-900
79. Cromer B.A., Blair J.M., Mahan J.D., Zibners L., and Naumovski Z. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives. J Pediatr 129 (1996) 671-676
80. Cromer B.A., Stager M., Bonny A., et al. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J Adolesc Health 35 (2004) 434-441
81. Elgan C., Samsioe G., and Dykes A.K. Influence of smoking and oral contraceptives on bone mineral density and bone remodeling in young women: a 2-year study. Contraception 67 (2003) 439-447
82. Elgan C., Dykes A.K., and Samsioe G. Bone mineral density changes in young women: a two year study. Gynecol Endocrinol 19 (2004) 169-177
83. Endrikat J., Mih E., Dusterberg B., et al. A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 microg or 30 microg ethinylestradiol in combination with levonorgestrel on bone mineral density. Contraception 69 (2004) 179-187
84. Gambacciani M., Spinetti A., Cappagli B., et al. Hormone replacement therapy in perimenopausal women with a low dose oral contraceptive preparation: effects on bone mineral density and metabolism. Maturitas 19 (1994) 125-131
85. Gambacciani M., Spinetti A., Taponeco F., Cappagli B., Piaggesi L., and Fioretti P. Longitudinal evaluation of perimenopausal vertebral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism. Obstet Gynecol 83 (1994) 392-396
86. Gambacciani M., Cappagli B., Ciaponi M., Benussi C., and Genazzani A.R. Hormone replacement therapy in perimenopause: effect of a low dose oral contraceptive preparation on bone quantitative ultrasound characteristics. Menopause 6 (1999) 43-48
87. Gambacciani M., Ciaponi M., Cappagli B., Benussi C., and Genazzani A.R. Longitudinal evaluation of perimenopausal femoral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism. Osteoporos Int 11 (2000) 544-548
88. Hansen M., Overgaard K., Riis B., and Christiansen C. Potential risk factors for development of postmenopausal osteoporosis-examined over a 12-year period. Osteoporos Int 1 (1991) 95-102
89. Lara-Torre E., Edwards C.P., Perlman S., and Hertweck S.P. Bone mineral density in adolescent females using depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol 17 (2004) 17-21
90. Mazess R.B., and Barden H.S. Bone density in premenopausal women: effects of age, dietary intake, physical activity, smoking, and birth-control pills. Am J Clin Nutr 53 (1991) 132-142
91. Nappi C., Di Spiezio S.A., Acunzo G., et al. Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception 67 (2003) 355-359
92. Nappi C., Di Spiezio S.A., Greco E., Tommaselli G.A., Giordano E., and Guida M. Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density. Obstet Gynecol 105 (2005) 53-60
93. Paoletti A.M., Orru M., Lello S., et al. Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol: observational study in young postadolescent women. Contraception 70 (2004) 293-298
94. Polatti F., Perotti F., Filippa N., Gallina D., and Nappi R.E. Bone mass and long-term monophasic oral contraceptive treatment in young women. Contraception 51 (1995) 221-224
95. Recker R.R., Davies K.M., Hinders S.M., Heaney R.P., Stegman M.R., and Kimmel D.B. Bone gain in young adult women. JAMA 268 (1992) 2403-2408
96. Reed S.D., Scholes D., LaCroix A.Z., Ichikawa L.E., Barlow W.E., and Ott S.M. Longitudinal changes in bone density in relation to oral contraceptive use. Contraception 68 (2003) 177-182
97. Shargil A.A. Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound: a three-year prospective study. Int J Fertil 30 (1985) 15-28
98. Taechakraichana N., Limpaphayom K., Ninlagarn T., Panyakhamlerd K., Chaikittisilpa S., and Dusitsin N. A randomized trial of oral contraceptive and hormone replacement therapy on bone mineral density and coronary heart disease risk factors in postmenopausal women. Obstet Gynecol 95 (2000) 87-94
99. Taechakraichana N., Jaisamrarn U., Panyakhamlerd K., Chaikittisilpa S., Limpaphayom K., et al. Difference in bone acquisition among hormonally treated postmenopausal women with normal and low bone mass. J Med Assoc Thai 84 Suppl 2 (2001) S586-S592
100. Volpe A., Amram A., Cagnacci A., and Battaglia C. Biochemical aspects of hormonal contraception: effects on bone metabolism. Eur J Contracept Reprod Health Care 2 (1997) 123-126
101. Weaver C.M., Teegarden D., Lyle R.M., et al. Impact of exercise on bone health and contraindication of oral contraceptive use in young women. Med Sci Sports Exerc 33 (2001) 873-880
102. Mais V., Fruzzetti F., Ajossa S., Paoletti A.M., Guerriero S., and Melis G.B. Bone metabolism in young women taking a monophasic pill containing 20 mcg ethinylestradiol: a prospective study. Contraception 48 (1993) 445-452
103. Volpe A., Silferi M., Genazzani A.D., and Genazzani A.R. Contraception in older woman. Contraception 47 (1993) 229-239
104. von Kesseru E., Etchepareborda J.J., Wikinski R., and Beier S. Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns. Contraception 61 (2000) 317-322
105. Massai R., Makarainen L., Kuukankorpi A., Klipping C., Duijkers I., and Dieben T. The combined contraceptive vaginal ring (NuvaRing) and bone mineral density in healthy premenopausal women. Hum Reprod 20 (2005) 2764-2768
106. Kanis J. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359 (2002) 1929-1936